martes, 5 de marzo de 2024

Why, Who, When, Where and More: New Draft Guidance on Notifying FDA about Discontinuance or Interruption in Manufacturing By Véronique Li, Senior Medical Device Regulation Expert & Deborah L. Livornese —

https://www.thefdalawblog.com/2024/03/why-who-when-where-and-more-new-draft-guidance-on-notifying-fda-about-discontinuance-or-interruption-in-manufacturing/?utm_source=rss&utm_medium=rss&utm_campaign=why-who-when-where-and-more-new-draft-guidance-on-notifying-fda-about-discontinuance-or-interruption-in-manufacturing

No hay comentarios: